|
|
Volumn 2, Issue 3, 2000, Pages 429-440
|
|
Thiazolidinediones: A comparative review of approved uses
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
GLIBENCLAMIDE;
INSULIN;
METFORMIN;
ORAL ANTIDIABETIC AGENT;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;
PHENFORMIN;
PIOGLITAZONE;
ROSIGLITAZONE;
SULFONYLUREA DERIVATIVE;
TROGLITAZONE;
BLOOD TOXICITY;
DRUG ABSORPTION;
DRUG APPROVAL;
DRUG EFFECT;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG SAFETY;
DRUG STRUCTURE;
EDEMA;
GENE EXPRESSION;
GLUCOSE TRANSPORT;
GLUCOSE UTILIZATION;
HUMAN;
INSULIN SENSITIVITY;
LIPID BLOOD LEVEL;
LIPID METABOLISM;
LIVER TOXICITY;
MONOTHERAPY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OVULATION;
PRIORITY JOURNAL;
REVIEW;
BLOOD GLUCOSE;
DIABETES MELLITUS, TYPE 2;
DRUG THERAPY, COMBINATION;
GENE EXPRESSION REGULATION;
HUMANS;
HYPOGLYCEMIC AGENTS;
THIAZOLES;
THIAZOLIDINEDIONES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0033759610
PISSN: 15209156
EISSN: None
Source Type: Journal
DOI: 10.1089/15209150050194297 Document Type: Review |
|
Times cited : (67)
|
|
References (11)
|
